TATs highly expressed in cervical cancer include CEACAM5, CD71, CD138, FGFR3, LYPD3, CEACAM6, etc.; VEGF is also highly expressed in ovarian cancer; CD71 and CD138 are highly expressed in endometrial cancer; the TATs highly expressed in uterine sarcoma include B7-H3, DLK1, and EFNA4. Here, CEACAM5 is linked to uterine corpus sarcoma.